前收市價 | 2.65 |
開市 | 6.10 |
買盤 | 4.30 |
賣出價 | 8.50 |
拍板 | 22.00 |
到期日 | 2024-05-17 |
今日波幅 | 6.10 - 6.10 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 96 |
Corcept (CORT) beats on both earnings and sales in the first quarter of 2024. The company increases revenue guidance for 2024.
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q1 2024 Earnings Call Transcript May 1, 2024 Corcept Therapeutics Incorporated beats earnings expectations. Reported EPS is $0.2503, expectations were $0.21. Corcept Therapeutics Incorporated isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank […]
Corcept (CORT) reports positive data from the open-label portion of the phase III GRACE study evaluating relacorilant for treating patients with Cushing's syndrome.